2026-03-20FDA approves nivolumab with chemotherapy for previously untreated Hodgkin lymphomaDrugs Opdivo (nivolumab) · Anti-PD-1 antibody, doxorubicin · AnthracyclineConditionLymphoid
2022-11-10FDA approves brentuximab vedotin in combination with chemotherapy for pediatric patients with classical Hodgkin lymphomaDrugs Adcetris (brentuximab vedotin) · Anti-CD30 antibody-drug conjugate, doxorubicin · AnthracyclineConditionLymphoid